Loading Events

Will you be attending the 3rd Annual Obesity & Weight Loss Drug Development Summit in Boston on July 14th to 16th, 2025?

Don’t miss our session on July 15th, Optimizing Patient Adherence in Clinical Trials: Behavioral Evaluation, Risk Prediction, and Personalized Digital Interventionism, which will be presented by Nicholas Alp, MD, PhD, Chief Medical Officer at Clinical ink. 

Let’s schedule a time to chat. Click the button below and fill out the form. Our team will be in touch to schedule a meeting during the conference.

Learn More About Our Technologies

GlucoseReady™: Glucose Monitoring That Transforms Cardiometabolic Clinical Trials
Monitor Diabetes Clinical Trials in Real Time
Scroll to Top

Let's Connect!

Please complete this form, and we’ll reach out to arrange a convenient time for us to meet.

Contact Clinical ink

Request more information, submit questions, set up a demonstration, and more.